Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00215202
Status:
COMPLETED
Last Update Posted:
2018-05-17
First Post:
2005-09-15
Brief Title:
Phase II Trial of ZD1839 Iressa in Patients With Nonresectable Adrenocortical Carcinoma ACC
Sponsor:
Dartmouth-Hitchcock Medical Center
Organization:
Dartmouth-Hitchcock Medical Center
Organization Data
Organization:
Dartmouth-Hitchcock Medical Center
Class:
OTHER
Study ID:
D0327
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Kentuckiana Cancer Institute | OTHER |
| AstraZeneca | INDUSTRY |
| MD Anderson Cancer Center | OTHER |
| Dana-Farber Cancer Institute | OTHER |